Elba del Val Oriza

Ms. Elba del Val Oriza

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
JCJulia M Coronas-Serna
Julia M Coronas-Serna
EOElba del Val Oriza
Elba del Val Oriza
JKJonathan C. Kagan
Jonathan C. Kagan
MMMaría Molina Martín
María Molina Martín
VCVictor Cid
Victor Cid
Toll-like receptor (TLR) signaling is key to detect pathogens and initiating inflammation. Ligand recognition triggers the assembly of supramolecular organizing centers (SMOCs) consisting of large complexes composed of multiple subunits. Building such signaling hubs relies on Toll Interleukin-1 Receptor (TIR) and Death Domain (DD) protein-protein interaction domains. We have expressed TIR domain-containing components of the human myddosome (TIRAP and MyD88) and triffosome (TRAM and TRIF) SMOCs in Saccharomyces cerevisiae, as a platform for their study. Interactions between the TLR4 TIR domain, TIRAP, and MyD88 were recapitulated in yeast. Human TIRAP decorated the yeast plasma membrane (PM), except for the bud neck, whereas MyD88 was found at cytoplasmic spots, which were consistent with endoplasmic reticulum (ER)-mitochondria junctions, as evidenced by co-localization with Mmm1 and Mdm34, components of the ER and Mitochondria Encounter Structures (ERMES). The formation of MyD88-TIRAP foci at the yeast PM was reinforced by co-expression of a membrane-bound TLR4 TIR domain. Mutations in essential residues of their TIR domains aborted MyD88 recruitment by TIRAP, but their respective subcellular localizations were unaltered. TRAM and TRIF, however, did not co-localize in yeast. TRAM assembled long PM-bound filaments that were disrupted by co-expression of the TLR4 TIR domain. Our results evidence that the yeast model can be exploited to study the interactions and subcellular localization of human SMOC components in vivo.

25 July 2025 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
EOElba del Val Oriza
Elba del Val Oriza
AFAlejandro Fernández-Vega
Alejandro Fernández-Vega
MMMaría Molina Martín
María Molina Martín
VCVictor Cid
Victor Cid
MyD88 is a key mediator of Toll-like receptor (TLR) signaling, orchestrating the innate immune response upon stimulation by pathogen-associated molecular patterns (PAMPs). Structurally, MyD88 consists of a Death domain (DD), a 20-amino acid N-terminal extension, and an intermediate (INT) region that connects it to a Toll/Interleukin-1 receptor (TIR) domain. At the core of the signaling complex known as myddosome, MyD88 undergoes homopolymeric interactions to propagate the signal. In this study, we use Saccharomyces cerevisiae as a heterologous model to assess the contribution of individual MyD88 domains to self-interaction and subcellular localization. In yeast, MyD88 localizes to endoplasmic reticulum-mitochondria encounter sites (ERMES). Here, we show that its DD is sufficient for attachment to the ERMES. Deletion of its 20 N-terminal residues increased MyD88 stability, shifting its aggregation pattern from patches to filaments. In contrast, a chimeric MyD88 variant bearing the plasma membrane-binding N-terminal extension of TIRAP, another TLR4-associated myddosome component, exhibited diffuse mitochondrial distribution. Moreover, we found that the ERMES-associated dynamin-like protein Dnm1, involved in mitochondrial fission, played a crucial role in MyD88 expression in yeast. On the other hand, the MyD88 TIR domain alone accumulated at lipid droplets in yeast, and its overexpression led to growth impairment and mitochondrial condensation. These findings suggest that MyD88 association with cellular membranes promotes self-assembly, a process essential for functional TLR signaling. Additionally, we adapted a tripartite GFP system to titrate MyD88 homopolymerization in yeast. Using this system, we observed that the oncogenic L252P mutation significantly reduced MyD88 ability to self-interact.

8 August 2025 in bioRxiv
Verified
Preprint
Open access
EOElba del Val Oriza
Elba del Val Oriza
GGGiulia Genna
Giulia Genna
TFTeresa Fernández-Acero
Teresa Fernández-Acero
MMMaría Molina Martín
María Molina Martín
VCVictor Cid
Victor Cid
Interleukin-1 receptor-associated kinases (IRAKs) are Ser/Thr protein kinases characterized by an N-terminal Death domain (DD). Upon stimulation of Toll-like receptors (TLRs) or the interleukin-1 receptor (IL-1R), IRAKs are recruited to supramolecular signalling complexes, known as myddosomes, through interactions between their DDs and the adaptor protein MyD88. Myddosomes are essential for the activation of nuclear factor kappa B (NF-κB) in response to diverse pathogen– and damage-associated molecular patterns (PAMPs and DAMPs), and they contribute to inflammation, cell survival, and proliferation. In the hierarchical assembly of the myddosome, MyD88 first recruits IRAK4, which serves as a scaffold for the subsequent binding of IRAK1 and/or IRAK2. To explore alternative models for studying IRAK function, we expressed human IRAK1, IRAK2 and IRAK4 individually in Saccharomyces cerevisiae and performed a comparative analysis. Heterologous expression of these kinases, especially IRAK4, impaired yeast growth; an effect dependent on its kinase activity. Transcriptomic and biochemical assays revealed that IRAK1 and IRAK4, but not IRAK2, differentially impacted metabolic regulation. Notably, IRAK4 induced mitochondrial fragmentation and mitochondrial membrane potential depolarization, whereas IRAK1 had the opposite effect. Additionally, IRAK4 led to actin depolarization and vacuole fragmentation. Based on these findings, we develop two yeast-based bioassays to screen for IRAK4 kinase inhibitors: one based on growth recovery and another using a fluorescent reporter. We provide proof-of-concept that both assays are suitable for evaluating IRAK4 function and its pharmacological inhibition. Importance: IRAK kinases are essential components of the myddosome signalling complex, a key mediator of the innate immune response, with IRAK4 playing a pivotal role in the recruitment of IRAK1 and/or IRAK2. Although the precise cellular functions of IRAK-dependent phosphorylation remain incompletely understood, IRAK inhibitors are emerging as promising therapeutic candidates for the treatment of autoimmune disorders, such as rheumatoid arthritis, and various cancers, including acute myeloid leukemia. To date, most insights into IRAK function have been derived from studies in animal models, particularly mice. Our work establishes Saccharomyces cerevisiae as a convenient and genetically tractable platform for in vivo analyses of human IRAKs. We demonstrate that IRAK kinases induce metabolic deregulation and growth inhibition in yeast. Engineered S. cerevisiae strains could therefore be exploited for the preclinical screening of anti-inflammatory and antitumor compounds targeting IRAK signalling, potentially contributing to the development of therapies for severe human diseases.